Try our Advanced Search for more refined results
Health - January, 2022
428 articles
- Opioid Pills Set Off 'Triple Wave' Of Addiction, Judge Hears
- 9th Circ. Won't Review DEA Letter On Medical Psilocybin Use
- UK Bill Would Waive IP On Pandemic Vaccines, Treatments
- NJ Justices Challenge Broad View Of Expert Affidavit Rule
- ICE Detainees Seek Booster Shots For Medically Vulnerable
- Elite Trial Lawyer Switches Sides To A Changing Plaintiffs Bar
- Feds Tell Jury Ex-Drug Co-Op CEO To Blame For Opioid Crisis
- Moderna COVID-19 Vaccine Gets FDA's Full OK
- 3rd Circ. Revives Claims Against Nurse Over Patient's Assault
- Pharmacies Can't Get 6th Circ. Review In Ohio Opioid Trial
- A Comparison Of High Court Rulings On Vaccine Mandates
- Health Care Software Co. Says Rival Poached Workers, Data
- DaVita Can't Duck Criminal Antitrust Suit Over No Poach Deals
- Nursing Home Tells 5th Circ. COVID Suit Belongs In Fed. Court
- Castlight Health Investor Sues Over $370M Vera Sale
- Keys To Keeping Law Firm Talent Amid The Great Resignation
- Cardinal Health Pays $13M To Settle Doctor Kickback Claims
- Investors In Pot Co. Aphria Seek Class Cert. In $144M Suit
- Medtronic Accused Of Stealing Rival's Sales Reps, Customers
- Diversified Healthcare Trust Inks $703M JV For Office Portfolio
- Health Care Group Of The Year: Morgan Lewis
- Insurers, WTA Reach Deal Over $10M Blood Test Arbitration
- Medical Imaging CEO Gets 5 Years In Prison For $250M Fraud
- Feds Snag Win In Tribal Challenge To COVID Fund Distribution
- CVS Drug Buyers Ask 9th Circ. For Redo Of $121M Trial
- Property Insurance Not For Virus Losses, Trade Group Argues
- DOL Says Employers Struggling With Mental Health Parity Law
- Drugmakers Won't Get Discovery From Valisure In Zantac MDL
- Cannabis Bill Roundup: SAFE Banking Gets Another Shot
- Purdue's Appeal On Ch. 11 Releases Fast-Tracked By 2nd Circ.
- Feds Say Health Care Execs Fixed Wages Amid Pandemic
- Lab Owners Aim To Duck $24M Medicaid Overpayment Claims
- Texas Justices Will Review $10.3M Cerebral Palsy Birth Verdict
- Immigration Policy Changes Are A Boon To STEM Employers
- Arizona Judge Is Latest To Block Contractor Vax Mandate
- Health Hires: Manatt, Garfunkel Wild
- Ex-CDC Worker's Bias Suit Should Get Spiked, Judge Says
- Pa. Worker Claims He Was Fired For Medical Pot Use
- Alston & Bird Nabs Former FDA Associate Chief Counsel
- Ga. County Joins Fight Over In-Network Health Insurance
- Health Care Group Of The Year: McDermott
- Strategies For Coping With Stress In The Legal Profession
- How Employers Can Determine COVID Test Mandate Costs
- Sichenzia Ross, Loeb Lead $2.5B Health Care Tech SPAC Deal
- 4 Highlights In Breyer's Legal Legacy For Health, Life Sciences
- 6 Breyer Product, Personal Injury Opinions Attys Should Know
- Judge Says Shkreli's Picasso Can Be Sold To Pay $2.6M Debt
- The Term: Breyer's Legacy And The Nomination To Come
- Fla. Judge Gives Cancer Patients Win Against Aetna
- Breyer Retiring As Supreme Court Lurches Right
- 3 Keys To Success For Health Care Private Equity Buyers
- 'Street Level' Oxy Pusher Admits Tricking Ex-CEO's Company
- All Pa. Counties Join $26B Opioid Deal Over DAs' Objections
- Vision Biz To Pay $3.5M For Violating Contact Lens Rule
- Offit Kurman Welcomes Health Care Atty To Harrisburg Office
- AGs Ask OSHA For Climate Change Heat Standards
- Ex-V&E Gov't Contracts Vice Chair Jumps To McDermott
- Impact Healthcare REIT Seeks To Raise $67M With Share Sale
- What You Need To Know About Judge Jackson
- Biden At His Side, Justice Breyer Announces Retirement
- 7th Circ. Dismisses Indiana Univ. Students' Vax Mandate Suit
- Democrats Plan Swift Confirmation Of Breyer Successor
- 4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan
- UHS Investors Get $2.5M Fees After 'Audacious' $5.7M Bid
- Mississippi Lawmakers Send Medical Pot Bill To Governor
- Meet The Possible Nominees For Justice Breyer's Seat
- Texas Gov. Asks State Justices To Affirm Mask Mandate Ban
- How AI Can Transform Crisis Management In Litigation
- OSHA Case Shows Fluidity Of Major Questions Doctrine
- Litigation Complicates Surprise Medical Bill Law Compliance
- 'Just Do Your Job': Justice Breyer's Legacy Of Pragmatism
- Ga. Health Care System Can't Shake $4.6M ERISA Class Action
- Blank Rome Adds Corporate Litigation Partner In Philly
- Tribal Corp. IP Suit Highlights Sponsored Research Pitfalls
- 5 Breyer Opinions You Need To Know
- Justice Breyer To Retire From High Court
- Kirkland-Led GTCR Clinches $2B Strategic Growth Fund
- 'Frankly Stunning': Distributors Pan DEA Vet At Opioid Trial
- NY Court Reporters Challenge Courthouse Vax Mandate
- Mass. Court Upholds Doc's Win In Spinal Surgery Suit
- Two Investor Settlements From 2021 Crack Top 100 List
- How Vaccine Mandates Impact Employment Insurance Policies
- Mallinckrodt, Fresenius Reach $14M Deal On Supply Claims
- Fla. Hospital Chain Must Face Part Of Antitrust Lawsuit
- Rhode Island Inks $91M Opioid Deal With Distributors
- The Insys Case Made History. Why An Exec's Appeal May Not
- Aliera Ch. 11 Cases To Be Consolidated In Del. Court
- Supervisor Relationships Are Key To Beating Atty Burnout
- Rite Aid Investors, Walgreens Ask To Slim Or Toss Merger Suit
- Texas Nursing Home Can't Dodge COVID Wrongful Death Suit
- Supplement Biz Says Rival Lies About Toxic Ingredients
- Texas Panel Sends $19M Reimbursement Case To Mediation
- Texas Hospital Can't Escape Pancreatitis Death Suit
- Health Care And Corporate Atty Joins Epstein Becker
- Distributor Urges 6th Circ. To Revive Opioid Coverage Suits
- Beyond Big: Smaller, Hyperfocused Firms Still Stand Out
- Drug Distributors' Order Reporting Had Flaws, Expert Testifies
- Inovio Fights Investor Class Cert. In COVID-19 Vaccine Suit
- NJ Court Revives Patient's Suit Over Botched Dental Implants
- 1st Circ. Affirms Broad Gov't Power To End FCA Suits
- Universal Health Says Chancery Class Suit Makes 'No Sense'
- Pharma Cos. Get Bystolic Generic Delay Claims Tossed
- Lionbridge Defeats TransPerfect's Trade Secrets Suit
- Ex-Compliance Boss Walks Fine Line At Oxy Conspiracy Trial
- USC Must Face Insurer's Bid To Rescind Excess Policy
- High Court To Skip Post-Firing Retaliation Fight In FCA Case
- UnitedHealth Files 2nd Suit Over $38M Merger Math Dispute
- Greenberg Traurig Adds Health Care Litigation Atty In NJ
- COVID Fuels Top Firms' Priorities In 2022
- The Leaderboard: Tracking A Firm's Litigation Footprint
- Meta, Snap's 'Addictive' Platforms Blamed For Child's Suicide
- Texas Judge Blocks Vaccine Mandate For Federal Workers
- Punitive Damages Give Cancer Survivor $10M Win Over RJR
- 9th Circ. Breathes New Life Into $50M Suit Against 49 Insurers
- Ga. Judge Grapples With Pot's Legal Status In Licensing Fight
- District Court Won't Hear J&J Talc Unit's Ch. 11 Stay Fight
- $26B Deal Keeps Opioid Files Of J&J, Distributors Out Of View
- Fla. Hospital Faces New Trial In Amputee's Recalled Drug Suit
- DOJ Sues Pharmacist For Filling Illegal Opioid Prescriptions
- 'Data-Rich' Sources Can ID Niaspan Class, 3rd Circ. Told
- Feds Say Nursing Home Owner Dodged $29.5M Payroll Tax Bill
- Lessons From Moderna's COVID Vaccine Patent Dispute
- Iowa Justices Order New Trial For Med Mal Stroke Suit
- Ariz. Oral Surgeon Escapes Suit Over Dental Implant Surgery
- Texas Justices Will Review Abortion Law Challenge
- Paul Hastings Expands DC Life Sciences Consulting Group
- 9th Circ. Says COVID Gun Shop Closures Defied Constitution
- Bill Paxton's Family Can Seek Punitive Damages From Cedars
- Okla. Law Firm Says Employee's Pot Licenses Suit Is A Dud
- EPA Says Fuel Importer Violated Clean Air Act
- Health Co. Gets ERISA Suit Booted To Arbitration
- Feds Urge High Court To Back Doctors' Opioid Convictions
- Covid Tester Escalates BCBS Pay Fight With Antitrust Claims
- Sutter Judge 'Optimistic' Virus Won't Further Delay Jury Trial
- Justices Again Decline To Streamline Texas Abortion Suit
- Clinical Trial Staffer Gets 30 Months For Research Fraud
- Real Estate Rumors: Wells Fargo, SL Green, Ram Realty
- Hemp Group Tells DC Circ. To Keep DEA Hands Off 'Hot' Crops
- GAO Unclear If HHS Is Prepared For Full COVID Vax Duties
- Alsup Mulls $113M Atty Fees In $454M Glumetza Antitrust Deal
- Drug Patent Suits' Novel Theory Tests False Claims Act Limits
- Investors Say Biotech Co. Altered Alzheimer Drug Data
- Latham, Davis Polk Guide Psychedelic Co.'s SPAC Merger
- HCA Monopolizes Orthopedic Surgeries In Florida, Suit Says
- Venture Wants Atty Fees Over CBD Cream Patent Row
- Fitness Center Asks 9th Circ. To Revive Virus Coverage Suit
- Insurer Wants Refund From Hawaiian Hospital For Abuse Suits
- 6 Maura Healey Cases To Know As Gov. Campaign Launches
- Pair Of Docs Must Pay $1M Over Misdiagnosed Ankle Break
- How Health Cos. Have Responded To Anti-Kickback Reform
- DaVita Tells Justices Not To Touch Win In Reimbursement Row
- 3rd Circ. Skeptical Of Reviving ERISA Row Over Asbestos In J&J Powder
- Smoking Was Bladder Cancer Patient's Choice, RJR Tells Jury
- Biden Seeks To Expel Migrant Families; DC Circ. Is Skeptical
- Starbucks Nixes Vax Rule After High Court Sinks OSHA Order
- Mississippi House Passes Medical Marijuana Legalization Bill
- Sanofi Tells 10th Circ. It Paid $36M To Access EpiPen Market
- Emails In Ex-CEO's Oxy Trial Cut Both Ways On Compliance
- The Hottest FCA Cases And Trends To Watch In 2022
- Access Bio Accused Of Breaching $120M COVID Test Kit Deal
- Drugmakers Want Discovery From Valisure In Zantac MDL
- Ill. COVID-19 Testing Cos. Falsified Results, Minn. AG Says
- Health Co. Can't Get 6th Circ. To Shut Down ACA Bias Suit
- School Nurse No-Poach Criminal Trial Moved To July
- Kaiser Says First-To-File Bar Breaks $1B Medicare Fraud Suits
- Ga. Hospital Seeks Dismissal Of 'Patient Dumping' Claims
- FTC Cracks Down On COVID Ad Claims Amid Omicron Surge
- Full Dallas Appeals Court Mulls Arbitration For Serial Killings
- The Rising Demand For Commercial Litigators In 2022
- Firms Seek $12M For $45M Surgery Partners Suit Settlement
- Cincinnati Fights New Evidence In Ohio High Court COVID Suit
- Canadian Model Wants $50M Allergan Unit Suit To Proceed
- Venable Adds 7 DC Health Care Experts From Faegre Drinker
- NJ Bankruptcy Judge Undoes Split Of J&J Tort Committee
- Parents Can Amend Suit Over Fla. COVID-19 School Rules Ban
- Marketer Says Racial Bias Drove Pa. Lab's Contract Breach
- No New Trial For Smith & Nephew Hip Implant Patient
- Boston Children's Retirement Plan Too Pricey, Suit Says
- Purdue Urges 2nd Circ. To Quickly Undo Ch. 11 Plan Rejection
- Pharma Biz Lied About COVID-19 Drug's Prospects, Suit Says
- ​​​​​​​Justices Call Solicitor General Into Fraud Standards Case
- Justices Turn Down NC Health Plan Transition Coverage Battle
- Justices Asked Not To Review Medical Pot Reimbursements
- Endo's Newest Opioid Deal Earmarks $65M For Fla.
- Sutter Calls Class' Bid For Chief Judge Intervention 'Improper'
- Florida Seeks End To Suit Over COVID-19 School Rules Ban
- Tyson Can't Escape COVID-19 Mandate Suit, Workers Say
- Tribe Says Its Opioid Suit Was Not Harmed By Dropped Claim
- Pharma Co. Gets Partial Win In Cancer Drug Contract Fight
- Reps. Float Bipartisan Bill To Improve Native American Health
- Antitrust's 1900s Nostalgia In The US And Beyond
- Cancer Nonprofit Exec Embezzled $3.7M, Feds Say
- Trade Group Turns To High Court In Seattle Benefits Law Fight
- Unvaccinated Ex-Aegerion Rep Can't Delay 4-Year Fraud Term
- Ex-CEO's Atty Blasts Feds' 'Sales Over Safety' Oxy Charges
- DOD Says Navy Vax Challengers Jumped Gun On Lawsuit
- Fla. Hospital Worker Gets $4M In T-Bone Accident Suit
- 9th Circ. Revives $8.6M Reimbursement Suit Against Cigna
- 5th Circ. Punts Abortion Challenge To Texas Supreme Court
- Akerman Appeals Counsel DQ In Medicare Repayment Row
- Teligent's 3 Ch. 11 Asset Sales Bring $87M Into Estate
- Norton Rose Avoids DQ In $340M COVID Coverage Suit In NY
- Teva, Glenmark Must Face Price-Fixing Suit At Same Trial
- 3 Firms Rep ProKidney's $2.64B Go-Public SPAC Deal
- Law360 Names Practice Groups Of The Year
- The Firms That Dominated In 2021
- 5 Questions After High Court Smacks Down Vax-Or-Test Rule
- Pharma Exec's Drug Trafficking Trial Tests Bold Legal Theory
- Judge Gives J&J Talc Unit's Ch. 11 Dismissal Bid Prominence
- War Exclusion Doesn't Bar Merck's $1.4B Cyber Loss
- Justices To Rule If Cops Can Be Sued For Miranda Violations
- Full Fed. Circ. Won't Revive Juno's $1.2B Cancer Patent Win
- Justices Correctly Used Shadow Docket In OSHA Vax Ruling
- Insys Founder Challenges Opioid Conviction At High Court
- Nebraska Sues County Health Official Over Mask Mandate
- Nursing Home Chain Wants To Trim $40M Bond Debt In Ch. 11
- Medical Practice Says Union Owes $576K For COVID-19 Tests
- Delaware Suit Means SPACs Will Face Tougher Legal Scrutiny
- Patients Can't Yet Score Win In UBH Surprise Billing Suit
- Orphan Drug Approval Takeaways From Recent FDA Data
- 'Pharma Bro No More' Shkreli Gets Industry Ban, To Pay $65M
- 3 Firms Guide Pair Of Tech-Focused SPACs Raising $511M
- Hospital Workers Target Fees Paid By $10B Retirement Plan
- What High Court Rulings Mean For Employer Vax Mandates
- Health Hires: Manatt, Oscar Health
- 5 Firms To Guide Eye Care Giant Bausch & Lomb's IPO Spinoff
- 'Horror Story' Logjam Will Bump Panasonic Trial, Judge Says
- Texas Physician, Hospital Must Face Patient Infection Suit
- IHS Finalizes Rule To Improve Buy Indian Act Implementation
- 'Someone Is Going To Get Sick': Sutter Judge Eyes Later Trial
- Boca Lab Owner Admits To $6.9M Medical Testing Scheme
- Mississippi Senate Advances Medical Pot Legalization Bill
- Texas AG Says Planned Parenthood Owes $10M
- Creditors Say Aliera Ch. 11 Needs To Stay In Delaware Court
- Health Care Co. Seeks Stay Of FCA Suit For High Court Appeal
- Attys Want $12M After Perrigo Tax Bill Settlement
- COVID 'Long Hauler' Says Disability Claim Wrongly Denied
- Glenmark's Ethics Allegations Against DOJ Rejected
- 5th Circ. Partially Revives Asbestos Suit Against Boeing
- NM Eye Practice's Virus Coverage Suit Survives Dismissal Bid
- How In-House Counsel Can Make The Case For Settling Early
- 2nd Circ. Rejects Biotech Investor's Media Defamation Suit
- Justices Sink Vax-Or-Test Rule But Clear Health Care Mandate
- Worker Says Wells Fargo Scared Her Out Of COBRA Coverage
- Sens. Move Forward Nominees For FDA Chief, Labor Dept.
- Court OKs Pharma Investors' $12.7M Deal Over Drug Trial
- NY Hospital, Physicians Must Face Amputee's Gangrene Suit
- Pandemic Put Deep Freeze On State Trials, New Data Show
- Cannabis Biopharma Co. Nabs CLO From Suboxone Maker
- 13 People Charged Over Alleged 'No-Fault' Insurance Crimes
- 2 Former Federal Prosecutors Head To BakerHostetler
- 8th Circ. Mulls Virus Exclusion COVID-19 Coverage Suit
- 7th Circ. May Hold Ind. Abortion Row For High Court Ruling
- Indian Health Service Must Face Patient's Sex Assault Suit
- Clinical Trial Co. Owner Admits Lying To FDA
- NY, NJ Health Centers Reach $7.5M Deal To End FCA Claims
- Ky. Dentist's COVID Coverage Loss Upheld By 6th Circ.
- To Retain Talent, GCs Should Prioritize Mission Statements
- How Health Cos. Can Minimize Consolidation Risk
- UnitedHealth Unit's Class Cert. Appeal Is Bunk, 7th Circ. Told
- Walgreens Sued Over 'Maximum Strength' Pain Relief Claims
- Quebec Plans Tax For Residents Who Don't Get COVID Vax
- Sutter Antitrust Trial Must Go On Despite COVID, Judge Told
- Judge Says Soldiers Should Seek Vax Waiver, Not Sue
- Cooley, Loeb & Loeb Shape $511M Medical Co. SPAC Merger
- Investment Firm Founder Asks 4th Circ. To Reinstate $8M Win
- What Attys Can Learn From Harvard Professor's Conviction
- Ex-Theranos CEO Elizabeth Holmes To Be Sentenced Sept. 26
- CMS Wants Narrow Coverage For Biogen's Alzheimer's Drug
- Sotomayor, Breyer Scrutinized In Feisty Senate COVID Hearing
- 7th Circ. Won't Resurrect Ill. Churches' COVID Closure Suit
- US Warns Of Russian Cyberattacks On Critical Infrastructure
- Ga. Justices Won't Touch Default Loss In Atty Malpractice Suit
- Omicron COVID Variant Is 'Relatively Mild,' Says Panasonic
- Cherokees Drop 'Public Nuisance' Theory In Opioid Bellwether
- Delaware AG Sues Over Seaford Abortion Ordinance
- Health Care Policy Priorities To Watch In 2022
- Judge Won't Lift Ch. 11 Injunction For J&J Talc Claims
- Dallas Courts Issue Delays Amid COVID Spike
- Gym Franchisees Tell 4th Circ. To Revive Virus Coverage Suit
- McKinsey Deal Not Enough For Opioid Costs, Mass. Suit Says
- Engineering Co. Still Faces Flint Water Study Claims At Trial
- 9th Circ. Skeptical Of Coverage For Co.'s Opioid Probe Costs
- Mich. Health Care Group Strikes $3M Deal In ERISA Suit
- Health Insurer Wants Delaware Ch. 11 Case Moved To Georgia
- Top 10 Whistleblowing And Retaliation Events Of 2021
- Punitive Damages Nixed From $10.5M Medical Sponge Verdict
- JPMorgan Exec Says Prudential Cut Benefits After Car Crash
- K&S Adds Former DOJ Litigator To Health Care Practice
- Boston Hospital Workers Urge 1st Circ. To Block Vax Mandate
- 5th Circ. Blasts Court For Sealing Records In Abortion Case
- GoodRx Beats IPO Suit Over Surprise Amazon Competition
- Biden Orders Health Insurers To Cover At-Home COVID Tests
- SPAC Investor Says Talkspace Misled On Costs, Demand
- Justices Told Fla. Can't Claim Part Of Injury Settlement
- Utah Pot Licensing Suit More Than Adequate, Court Told
- LAPD Workers' COVID-19 Vax Mandate Challenge Tossed
- Health System's Virus Coverage Suit Sent Back To State Court
- Calif. AG Clears Split Of Health Systems With Commitments
- Calif. Gov. Would Restore NOLs, Biz Credits In Budget
- NJ Legislature Passes Bill To Guarantee Right To Abortion
- Regeneron Wins Access To FDA Docs In Kickback Suit
- Ill. Panel Lets Medical Group Out Of Cardiac Negligence Suit
- KKR Clinches $4B Health Care Growth Equity Fund
- High Court Won't Hear Off-Label Ad Suit Against Taro
- Chancery Rejects Fast-Tracking Of $6.7B Arena Merger Suit
- Kirkland, Simpson Thacher Rep $1.45B Owens & Minor Deal
- Kirkland, Ropes & Gray Rep R1's $4B Cloudmed Buy
- Justices Pass On Alarm Co. Worker's FMLA Retaliation Case
- Pa. Panel Restores Psychiatric Records' Privilege In Birth Suit
- Dykema Opens Milwaukee Office With Capital Markets Laterals
- Calif. Gov. Signs Order Barring COVID Test Price-Gouging
- Duane Morris, Sidley Steer Four Springs' $252M IPO Launch
- Decision Delayed On Whether Talc Spinoff Stay Shelters J&J
- High Court Won't Revive Pa. COVID-19 Restrictions Suit
- Harvard Won't Have To Pay Prof's Legal Tab In China Case
- Justices To Review Nuclear Workers' Comp. Law
- Ex-Theranos COO May Face Trial Delay Due To COVID Surge
- 11th Circ. Won't Rehear Catalyst's Win In 'Orphan Drug' Case
- 5th Circ. Mulls Punting Texas Abortion Fight To State Court
- Cannabis Bill Roundup: Lawmakers Kick Off 2022 Sessions
- 'You Can't Kill Patients': Justices Open To CMS Vaccine Rule
- How Attys For Long Island Counties Notched Opioid Trial Win
- Investors Sue Health Insurer Over COVID-Linked Costs
- Deals Attys Approach JPMorgan Event Cautiously Optimistic
- Up Next At High Court: Medicaid Clawback, Day-Late Tax Case
- Stockholder Sues To Block Pfizer's $6.7B Arena Pharma Buy
- Walgreens' Settlement History Will Stay Out Of SF Opioid Row
- The State Of FDA Regulation Of Software As A Medical Device
- Calif. Says Stopping Pay-For-Delay Ban Went 'Too Far'
- 3rd Circ. Affirms Pharmacy Owner's Tax Fraud Conviction
- NJ Judge Won't Recuse Herself From Nursing Home Suit
- Purdue Ch. 11 Appeal Can Go To 2nd Circ., NY Judge Rules
- FisherBroyles Adds Attys From Jones Day, Polsinelli
- Justices' Texas Abortion Ruling Is Murky On Key Question
- High Court Grapples With Impact Of Blocking Vax-Or-Test Rule
- Illumina Investor Sent To Prison During Insider Trading Appeal
- 8th Circ. Ruling Sets Road Map For Disability Benefit Reviews
- Generics Catch A Break With Hikma's Skinny Label Win
- Mallinckrodt Says Ch. 11 Plan Fair For Acthar Claimants
- Calif. Tax Plan Would Fund Single-Payer Health Care
- NJ Lawmakers Advance Bill To Enshrine Right To Abortion
- Texas Court Ends Patient's Fraud Suit Against Hospital
- Workplace Vaccine Rules Take Center Stage At High Court
- Ex-CEO Says Barnes & Thornburg Conflict Hurt His Defense
- A Tale Of Two Cases: Lessons In No-Poach Litigation
- Texas Gov. Loses Third Appeal Over Mask Mandate Ban
- Policyholder Attys Hail Wash. Justices' Entry Into Virus Fight
- Bipartisan Bill Would Give Tribes Access To Medical Stockpile
- 2nd Circ. Rips 3rd Circ. Over Faxed Survey TCPA Ruling
- Loeb & Loeb Hires White And Williams' Securities Group Chair
- States Oppose Purdue's 2nd Circ. Appeal Try In Ch. 11 Case
- Class Attys Get $20M From UnitedHealth ERISA Win
- Hawaiian Airlines Workers Sue To Block Vaccine Mandate
- Mylan Can't Exclude Ex-CEO From EpiPen Antitrust Trial
- Ex-Owners' Antitrust Claim Denied After Buyers Close Firm
- Del. Justices Toss SmileDirectClub Stockholder Deal Appeal
- ICE Watchdog Finds Medical Issues At Shuttered Ga. Facility
- How Congressional Oversight May Shift In 2022 And Beyond
- No DQ For NY Fed. Prosecutor In Opioid Case Against Ex-CEO
- Epstein Becker Adds To Health Care Group In Tenn., Ohio
- Inovalon Investors Seek Stock Appraisal After $7.3B Sale
- Recent Bias Suits Against Law Firms And Lessons For 2022
- Damages Award Nixed In Child's MMR Vaccine Injury Dispute
- Health Plan Servicers' Disclosure Rule Objections Are Faulty
- Skadden-Led Stryker Buys $3.09B Health Care Software Maker
- Split 6th Circ. Won't Stay Contractor Vax Mandate Injunction
- 5th Circ. Critical Of DOL In Data-For-Insurance ERISA Case
- Ex-DEA Official Says Cardinal 'Barely' Monitored For Opioids
- 9th Circ. Seeks Help In Wash. $10M Wrongful Birth Verdict
- Ohio Home Health Care Co. Settles FCA Case, Agrees To Close
- Stockholders Sue AmerisourceBergen In Del. Over Opioids
- Teva Urges Judge To Limit Walgreens, CVS Antitrust Claims
- DC Circ. Denies Texas Arg Time In Migrant Expulsion Suit
- Ex-Medical Debt Collector Execs Cop To $1.5B Ponzi Scheme
- $20M Acquisition Would End Maryland Pot Biz Feud
- Medicare Advantage Plans Must Beware DOJ Scrutiny
- Harter Secrest Nabs Ex-Vanderbilt Medical CCO As Partner
- Navy Vaccine Religious Exemption Ruling Warrants Scrutiny
- Garfunkel Wild Adds Ex-Health Tech GC As Partner
- Saul Ewing Arnstein & Lehr Adds Health Care Counsel
- Kirkland, Fenwick Guide $370M Vera-Castlight Merger
- 4 Takeaways From Elizabeth Holmes' Fraud Verdict
- Nevada Says It's Joining $26B Deal With Opioid Distributors
- Texas Abortion Providers Ask Justices To Speed Up SB 8 Suit
- Arizona Not Harmed By Vax Mandate, Biden Admin. Says
- No 'Safe Harbor' For Gene Therapy Found In Hatch-Waxman
- Cannabis Co. Trulieve Escapes Investors' Moldy Pot Suit
- Acthar Claimants Call Mallinckrodt's Ch. 11 Plan Unfair
- Opioid Claims Involving McKinsey Should Be Axed, States Say
- Labcorp To Provide Nursing-Mom Rooms After DOL Probe
- How To Navigate The Coming Antitrust Policy Tests
- Generic Drug Cos., Takeda Escape Gout Drug Antitrust Suit
- Ga. Judges Uphold 'Harsh' Sanction Against Dental Clinic
- Texas Sues Biden Admin. Over National Guard Vax Mandate
- Nimbus, Bristol-Myers Drop Psoriasis Drug Dispute
- DC Circ. Revives Terror-Funding Case Against AstraZeneca
- Merit Medical's $18.25M Investor Fraud Deal Gets First OK
- Walgreens Workers Attys Seek $4.6M In Sweeping ERISA Case
- NY Hospital Equipment Co. Settles DOL ERISA Probe
- GSK Ex-Worker Cops To Trade Secrets Theft
- Holland & Knight, Sidley Rep $340M Health Care Software Sale
- Boston Scientific Says Dead-End SEC Probe Sinks Stock Suit
- Purdue's 2nd Circ. Appeal Request To Get Quick Decision
- Judge Calls Navy's Religious Vax Exemption Process 'Theater'
- AdventHealth Settles DOJ Case Over Deaf Patient Care
- U. Of Chicago Prof Pleads Not Guilty To Insider Trading
- How The ERISA Landscape May Shift This Year
- 5th Circ. Questions Success Of United Vax Mandate Challenge
- Jury Convicts Ex-Theranos CEO Elizabeth Holmes Of Fraud
- Holmes Jury Tells Judge It's Deadlocked On 3 Of 11 Counts
- ERISA Cases To Keep An Eye On In 2022
- Bankruptcy Cases To Watch In 2022
- Associate Hiring Outlook At Law Firms Is Bright For 2022
- A Look At What's Ahead For Antitrust Enforcement In 2022
- Merger Cases, Issues To Watch In 2022
- Florida Legislation To Watch In 2022
- The Antitrust Conduct Cases To Watch In 2022
- High Court To Scrutinize Vaccine Rules As 2022 Kicks Off
- A Blockbuster Year Ahead For Health, Life Sciences Litigation
- Buckle Up: Wild Ride Awaits Health, Life Sci Policy In 2022
- Texas Cases To Watch In 2022
- Product Liability Regulation, Legislation To Watch: 2021
- Cybersecurity & Privacy Cases To Watch In 2022
- 'Remain In Mexico' Renewal May Bring More Solo Migrant Kids
- 2022 Trials To Watch: Opioids, Oracle And Theranos Redux
- Personal Injury And Med Mal Cases To Watch In 2022
- Product Liability Cases To Watch In 2022